EPO patent filings show strong growth in materials, food technology, coatings and surface technologies, highlighting innovation driven by sustainability and advanced manufacturing.
Discover the key patent portfolio questions investors ask during IP due diligence and how chemistry and materials companies can strengthen investor confidence and support fundraising success.
New UK IPO guidance following the Emotional Perception AI ruling brings greater clarity to patent examination, aligning UK practice with the EPO and impacting AI, software and quantum computing inventions.
Discover how Tyruko compares with Tysabri, including biosimilar approval, manufacturing and formulation differences, patent considerations and the investigation into reported adverse patient outcomes.
Eminem has suffered a setback in his Australian dispute with Swim Shady. The ruling highlights why trade mark owners must file strategically and retain evidence of genuine use.
From 1 August 2026, Jersey becomes an independent Madrid System designation. Brand owners must separately designate Jersey for new filings, renewals and subsequent designations.
From 9 July 2026, Algeria’s accession to the Hague Apostille Convention will simplify document attestation for IP matters between member countries, replacing multi-stage legalisation with Apostille.
Swatch’s US$170m claim against Samsung could reshape UK trade mark damages by recognising the commercial value of brand reputation, exclusivity and goodwill in the digital economy.
The EASYBREATH and Elvie decisions show how technical function can limit design protection and why evidence of aesthetic design choices remains crucial.
The NHS is introducing an injectable form of Keytruda (pembrolizumab), reducing administration time to under two minutes and helping improve patient experience.
